Balance Sheet Data

Immunocore Holdings plc (IMCR)

$63.74

+4.42 (+7.45%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 124.3873.97129.72237.89148.58155.46162.67170.20178.09
Total Cash (%)
Account Receivables 38.5145.5816.7117.1531.9533.4334.9836.6038.29
Account Receivables (%)
Inventories ---------
Inventories (%)
Accounts Payable 6.4415.735.787.509.439.8710.3310.8111.31
Accounts Payable (%)
Capital Expenditure -3.54-4.28-3.07-1.01-3.16-3.31-3.46-3.63-3.79
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.